Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.
| Issuer | % of Class | Filed |
|---|---|---|
|
AgomAb Therapeutics NV
13G
AGMB · 00860C102
|
5.7% |
5/6/2026
Event 3/31/2026
|
|
Innate Pharma SA
13G/A
45781K105
|
9.1% |
4/29/2025
Event 4/23/2025
|